Insider · CIK 0001385155
David P Meeker
Files at TRVI (Trevi Therapeutics, Inc.), RYTM (RHYTHM PHARMACEUTICALS, INC.). First filing Jun 5, 2025, latest Sep 14, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RYTM: RHYTHM PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | RHYTHM PHARMACEUTICALS, INC. | $5.1M 50,000 shares | -17% | +35% from low-13% from high | |
| 35Weak | RHYTHM PHARMACEUTICALS, INC. | $2.8M 43,620 shares | -18% | +40% from low-2% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +50,000 | $6.05 | $303k | 289,258 | 28 d ago |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,439 | $101.75 | $655k | 282,819 | 28 d ago |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -30,746 | $102.35 | $3.1M | 252,073 | 28 d ago |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -8,698 | $103.43 | $900k | 243,375 | 28 d ago |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,817 | $104.55 | $190k | 241,558 | 28 d ago |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,300 | $105.19 | $242k | 239,258 | 28 d ago |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 15,431 | 28 d ago |
| Jun 11, 2025 | TRVI Trevi Therapeutics, Inc. | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jun 13, 2025 |
| Jun 3, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +43,620 | $4.59 | $200k | 245,445 | Jun 5, 2025 |
| Jun 3, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -43,346 | $65.04 | $2.8M | 202,099 | Jun 5, 2025 |
| Jun 3, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -274 | $65.60 | $18k | 201,825 | Jun 5, 2025 |
| Jun 3, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -43,620 | $0.00 | $0 | 0 | Jun 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.